IP Library Granted Patent US 10,551,321
Granted Patent B2
US 10,551,321 · App. 15/766,516 · Granted Feb 4, 2020

Device and method for detecting and/or evaluating pathological states

Inventors: Karin Schütze (Tutzing, DE); Raimund Schütze (Tutzing, DE); Waldemar Lernhardt (Oberslum-Sülzbach, DE)
Assignee: CellTool GmbH
G01N21/65G01J3/44G01N2021/656G06N20/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,551,321
App. No.
15/766,516
Granted
Feb 4, 2020
Kind
B2
Abstract

The invention relates to a device ( 1 ) for detecting and/or evaluating a pathological condition comprising a Raman spectroscopy system ( 10 ) and an electronic evaluation device ( 20 ), which is configured to perform a detection and/or evaluation of the pathological condition in accordance with an evaluation of at least one Raman spectrum detected in stroma.

Claims (36)

1. A device for detecting or evaluating a pathological condition, comprising

a Raman spectroscopy system;

an electronic evaluation device which is configured to perform a detection or assessment of the pathological condition depending on an evaluation of at least one Raman spectrum detected in stroma; and

at least one controllable motor operative to induce a relative movement between a stroma tissue sample and optical components of the Raman spectroscopy system in order to automatically capture the at least one Raman spectrum at a plurality of positions of the stroma tissue sample.

2. The device according to claim 1 , wherein the electronic evaluation device is configured to perform the detection or assessment of a tumor depending on the evaluation of the at least one Raman spectrum detected in the stroma outside a tumor.

3. The device according to claim 2 , wherein the electronic evaluation device is configured to retrieve reference data for detecting or evaluating the tumor depending on a tumor type of the tumor.

4. The device according to claim 2 , wherein the tumor is selected from a group consisting of:

a breast tumor,

a pancreatic tumor,

a colon tumor,

a lung tumor,

a thyroid tumor,

a stomach tumor,

an ovarian tumor.

5. The device according to claim 1 , wherein the electronic evaluation device is configured to perform a grading of a tumor depending on the at least one Raman spectrum.

6. The device according to claim 1 , wherein the electronic evaluation device is configured to determine, depending on the at least one Raman spectrum, whether a tumor is aggressive or non-aggressive.

7. The device according to claim 1 , wherein the electronic evaluation device is configured to detect endometriosis via evaluation of the at least one Raman spectrum in the stroma of an endometrium.

8. The device according to claim 1 , wherein the electronic evaluation device is configured to apply a support vector machine to data obtained from the at least one Raman spectrum.

9. The device according to claim 8 , wherein the electronic evaluation device is configured to subject the at least one Raman spectrum to a principal component analysis and apply the support vector machine to identified major components.

10. The device according to claim 8 , wherein the support vector machine has a linear kernel.

11. The device according to claim 1 , comprising:

a sample holder adapted to hold the tissue sample for Raman spectroscopy, wherein the device is configured to apply an excitation beam of the Raman spectroscopy system from a lower side of the sample holder to the tissue sample.

12. A method for detecting or evaluating a pathological condition, comprising

detecting at least one Raman spectrum,

evaluating the at least one Raman spectrum by an electronic computing device, wherein at least one Raman spectrum detected in stroma is evaluated by the electronic computing device for detection or assessment of the pathological condition; and

inducing a relative movement between a stroma tissue sample and optical components of the Raman spectroscopy system in order to automatically capture the at least one Raman spectrum at a plurality of positions of the stroma tissue sample.

13. The method according to claim 12 , wherein, depending on the evaluation of a Raman spectrum detected in the stroma outside a tumor, the detection or assessment of the tumor is performed.

14. The method according to claim 13 , wherein the electronic evaluation device retrieves reference data, which are used for the detection or assessment of the tumor, depending on a tumor type.

15. The method according to claim 13 , wherein the tumor is a breast tumor, a pancreatic tumor, a colon tumor, lung tumor, thyroid tumor, a stomach tumor, or an ovarian tumor.

16. The method according to claim 12 , wherein the electronic computing device performs a grading of a tumor depending on the at least one Raman spectrum.

17. The method according to claim 12 , wherein the electronic evaluation device determines, depending on the at least one Raman spectrum, whether a tumor is aggressive or non-aggressive.

18. The method according to claim 12 , wherein the electronic evaluation device detects an endometriosis by evaluating the at least one Raman spectrum detected in the stroma of an endometrium.

19. The method according to claim 12 , wherein the electronic evaluation device uses a support vector machine on data obtained from the at least one Raman spectrum.

20. The method according to claim 19 , wherein the electronic evaluation device subjects the at least one Raman spectrum to a principal component analysis and applies the support vector machine to identified major components.

21. The method according to claim 19 , wherein the support vector machine has a linear kernel.

22. The method according to claim 12 , wherein an excitation beam of a Raman spectroscopy system is applied from a lower side of a sample holder to the stroma tissue sample.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 062956 FRAME: 0445. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 28, 2023
From: CELLTOOL GMBH
To: MICROPHOTONX GMBH
Reel/Frame 064780/0651 →
PURCHASE AGREEMENT Recorded Mar 6, 2023
From: CELLTOOL GMBH
To: MICRO-PHOTONIX GMBH
Reel/Frame 062956/0445 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2019
From: LERNHARDT, WALDEMAR
To: CELLTOOL GMBH
Reel/Frame 048896/0416 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: SCHUTZE, KARIN; SCHUTZE, RAIMUND
To: CELLTOLL GMBH
Reel/Frame 045459/0814 →
Priority Claims (1)
DE 10 2015 219 349 · Oct 7, 2015 · national
Continuity (1)
Related Publication 20180292323A1 · Oct 11, 2018